Cargando…

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012

BACKGROUND: Unplanned pregnancy is a significant problem in Australia. Local data pertaining to use of the levonorgestrel-releasing intra-uterine device (LNG-IUD), and associated factors are limited. The aim of this analysis was to calculate prescribing rates of the LNG-IUD in Australia, including t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bingham, Amie L., Garrett, Cameryn C., Bayly, Christine, Kavanagh, Anne M., Keogh, Louise A., Bentley, Rebecca J., Hocking, Jane S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257965/ https://www.ncbi.nlm.nih.gov/pubmed/30482186 http://dx.doi.org/10.1186/s12905-018-0680-3

Ejemplares similares

Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study
por: Garrett, Cameryn C., et al.
Publicado: (2015)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016)

Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
por: Creinin, Mitchell D., et al.
Publicado: (2023)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo
por: Cavrois, Marielle, et al.
Publicado: (2019)

An Interesting Image of Transmural Migration of a Levonorgestrel-Releasing Intrauterine Device (LNg-IUD)
por: Mitranovici, Melinda-Ildiko, et al.
Publicado: (2022)

The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report
por: Cui, HaiHong, et al.
Publicado: (2023)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
por: Roland, Noémie, et al.
Publicado: (2022)

Cornual pregnancy as a complicaton of the use of a levonorgestrel intrauterine device: a case report
por: Beltman, JJ, et al.
Publicado: (2009)

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*
por: Ørbo, A, et al.
Publicado: (2014)

Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study
por: Chen, Shuyi, et al.
Publicado: (2020)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Decision-making regarding immediate vs. interval postpartum levonorgestrel intrauterine device insertion timing
por: Davenport, Abigail, et al.
Publicado: (2023)

Chronic Urticaria Suspected to be Caused by a 13.5 mg Levonorgestrel Intrauterine Device (Skyla®)
por: Ganguli, Malika P, et al.
Publicado: (2023)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression
por: Morrison, Charles S., et al.
Publicado: (2020)

Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report
por: Zeiss, René, et al.
Publicado: (2020)

Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
por: Pino, Ida, et al.
Publicado: (2022)

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?
por: van der Heijden, Patty A.H.H., et al.
Publicado: (2022)

Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer
por: Wei, Hongyi, et al.
Publicado: (2023)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
por: Hubacher, David
Publicado: (2015)

Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis
por: Sergison, Jill E., et al.
Publicado: (2019)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Factors affecting uptake of the levonorgestrel-releasing intrauterine device: A mixed-method study of social franchise clients in Nigeria
por: Brunie, Aurélie, et al.
Publicado: (2021)

Patient acceptability, continuation and complication rates with immediate postpartum levonorgestrel intrauterine device insertion at caesarean section and vaginal birth
por: Wojcik, Natasha, et al.
Publicado: (2022)

Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer
por: Chaudhari, Sonal R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rq2fvet5cqnqtl2r58o2dudp4o